Sera from 123 volunteers vaccinated six to 16 years previously with one of four rubella vaccines (Cendehill, RA27/3, HPV77-DE5, and To-336) were tested for rubella antibodies by single radial haemolysis and radioimmunoassay. By radioimmunoassay 110 (894%) of the vaccinees had antibody concentrations greater than the minimum immune titre (that is, > 15 000 IU/1), 11 (8 9%) were seropositive but had concentrations < 15000 IU/1, and two (1-6%) were seronegative. Eight (6-5%) were seronegative by single radial haemolysis, of whom five had received Cendehill vaccine. Six to eight years after vaccination subjects who had received Cendehill vaccine had the lowest geometric mean titre of antibody by radioimmunoassay while the subjects who had received HPV77-DE5 vaccine had the highest. Although antibody concentrations < 15 000 IU/l were not detected among subjects given RA27/3 vaccine six to eight years previously, such low levels were detected in two (154%) vaccinated 11-16 years previously.
vaccine, however, but also on the persistence of antibody throughout childbearing years. Thus adequate antibody concentrations must persist for at least 30 years after vaccination of 11-to 14-year-old schoolgirls in the UK and for even longer in the US, where most children are vaccinated before entering school. Some concern was expressed in the US over reports from Horstmann1 and Balfour and Amren2 that 8-5% and 36% of children respectively no longer had detectable haemagglutination-inhibiting antibody three to nine years after vaccination with HPV77-DE5 (Meruvax-l) vaccine. As a result of these findings the need for revaccination was discussed.3 More recently, however, Herrmann et a14 reported loss of antibody in less than 3% of children vaccinated with HPV77-DE5 vaccine 10 years previously. Recent studies in the UK5 have also been encouraging, showing that over 90% of subjects who received RA27/3 (Almevax) or Cendehill (Cendevax) vaccines six to seven years previously had adequate antibody titres. Similarly, studies in the Irish Republic have shown persistence of antibody for up to 10 years after vaccination with RA27/3 vaccine. 6 We report a study in which we tested sera obtained in 1981 from adult female volunteers vaccinated up to 16 years previously with one of four rubella vaccines. Some of these women were among the earliest rubella vaccinees in the UK, and these sera therefore represent a unique collection. Earlier studies generally used only titres of haemagglutination-inhibiting antibody to assess persistence of rubella antibodies. In this study sera were tested by single radial haemolysis and radioimmunoassay, both of which are more sensitive than tests for haemagglutination-inhibiting antibody, particularly in detecting low levels of antibody.7
Subjects and methods
We studied two groups of volunteers. The first had been vaccinated with RA27/3, Cendehill, HPV77-DE5, or a Japanese vaccine, To- 
Patients and methods
We studied 20 patients with colitis (see table) . In all cases the diagnosis was confirmed histologically. Spread to the small bowel in patients with Crohn's disease was excluded by barium follow-through. From clinical and histological assessment, 17 patients had active colitis and three inactive disease. Colonoscopy was available within two weeks of the scan in six patients (three with active and all three with inactive disease). Nine patients were receiving treatment in the form of steroids or sulphasalazine at the time of the scan.
Radiology-Double-contrast barium enema was performed in 19 patients. The remaining patient was considered too ill for the procedure and the extent of disease was assessed by late barium followthrough films and confirmed by surgery. The extent of colitis was assessed by the radiologist performing the barium study (who was unaware of the result of the leucocyte scan) and classified according to regional disease, regions 1, 2, and 3 corresponding to descending, transverse, and ascending colon, respectively. Radiology was performed within two weeks of the leucocyte scan in 17 patients. In the remaining three barium enema was performed three to four months before the scan.
Scanning-Leucocytes were labelled either in saline with 'In-acetylacetonate (eight patients)12 or in plasma with "'1In-tropolonate (12 patients).13 Abdominal scans were performed within four
